Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our aim is to understand fundamental biological processes that could inform the development of targeted therapies and innovative biomarkers in neurodegenerative and neurogenetic disorders.

We are investigating disease mechanisms at different levels
We are investigating disease mechanisms at different levels

The group was established by Dr Tofaris in 2013 and aims to investigate cellular and biochemical mechanisms that are a common theme in age-related neurodegenerative and rare neurogenetic disorders. We are using Drosophila and iPSc-derived neurons as model systems and various biochemical assays to understand enzymatic processes that could be targeted for drug therapies. We are especially interested in the ubiquitin pathway by which cells degrade misfolded proteins or damaged organelles. In collaboration with the Department of Chemistry in Oxford, we are developing biomarkers of progression in Parkinson's disease.  We also have collaborative projects within the EU IMI Consortium IMPRiND.


Wellcome logo BMA
Oxford BRC EU IMI logo





Selected publications

Related research themes